Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: A multicenter-longitudinal study

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Galante, Mariana ^a,b   Garin, Olatz ^a,b,c   Sicuri, Elisa ^a,d   Cots, Francesc ^a,b   García Altés, Anna ^a,e   Ferrer, Montserrat ^a,b,f   Dominguez, Àngela ^a,g   Alonso, Jordi ^a,b,c  

^a CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e Catalan Agency for Health Information   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ABSENTEEISM; ADOLESCENT; ADULT; AGED; ARTICLE; CAREGIVER; CHILD; COMORBIDITY; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; OBSERVATIONAL STUDY; OUTPATIENT; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY ANALYSIS; SPAIN; CLINICAL TRIAL; ECONOMICS; HEALTH SERVICE; INFLUENZA; INFLUENZA VIRUS A H1N1; MULTICENTER STUDY; PANDEMIC; UTILIZATION REVIEW;

HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; PANDEMICS; SICK LEAVE; SPAIN;

EID: 84856945351     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031696     Document Type: Article

References (43)

1. Badia Llach X, Roset Gamisans M, Frances Tudel JM, Alvarez Sanz C, Rubio Terrés C, (2006) [Study of flu costs]. Aten Primaria 38: 260-267.
2. Ampofo K, Gesteland PH, Bender J, Mills M, Daly J, et al. (2006) Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 118: 2409-2417.
3. Esposito S, Cantarutti L, Molteni CG, Daleno C, Scala A, et al. (2011) Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect 62: 379-387.
4. Neuzil KM, Maynard C, Griffin MR, Heagerty P, (2003) Winter respiratory viruses and health care use: a population-based study in the northwest United States. Clin Infect Dis 37: 201-207.
5. Sierra Moros MJ, Vazquez TM, Santa-Olalla PP, Limia SA, Cortes GM, et al. (2010) [Epidemiological surveillance activities during the 2009 influenza pandemic in Spain: lessons learnt one year after]. Rev Esp Salud Publica 84: 463-479.
6. Keren R, Zaoutis TE, Saddlemire S, Luan XQ, Coffin SE, (2006) Direct medical cost of influenza-related hospitalizations in children. Pediatrics 118: e1321-e1327.
7. Hassan F, Lewis TC, Davis MM, Gebremariam A, Dombkowski K, (2009) Hospital utilization and costs among children with influenza, 2003. Am J Prev Med 36: 292-296.
8. Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, et al. (2009) Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361: 1925-1934.
9. Larrauri CA, Jimenez-Jorge S, Simon ML, de Mateo OS, (2010) [Surveillance of influenza pandemic (H1N1)2009 in Spain]. Rev Esp Salud Publica 84: 569-588.
10. Santa-Olalla PP, Cortes-Garcia M, Vicente-Herrero M, Castrillo-Villamandos C, Arias-Bohigas P, et al. (2010) Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April-December 2009. Euro Surveill 15: pii 19667-pii 1975.
11. Simmerman JM, Lertiendumrong J, Dowell SF, Uyeki T, Olsen SJ, et al. (2006) The cost of influenza in Thailand. Vaccine 24: 4417-4426.
12. Lambert SB, Allen KM, Carter RC, Nolan TM, (2008) The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children. Respir Res 9: 11-21.
13. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, et al. (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25: 5086-5096.
14. Karageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME, (2011) Age Distribution of Cases of 2009 (H1N1) Pandemic Influenza in Comparison with Seasonal Influenza. PLoS One 6: e21690-e21698.
15. Tora-Rocamora I, Delclos GL, Martinez JM, Jardi J, Alberti C, et al. (2011) Occupational health impact of the 2009 H1N1 flu pandemic: surveillance of sickness absence. Occup Environ Med.
16. Smith RD, Keogh-Brown MR, Barnett T, Tait J, (2009) The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment. BMJ 339: b4571-b4577.
17. Brouwers L, Cakici B, Camitz M, Tegnell A, Boman M, (2009) Economic consequences to society of pandemic H1N1 influenza 2009- preliminary results for Sweden. Euro Surveill 14: pii 19333-pii 19339.
18. Keogh-Brown MR, Smith RD, Edmunds JW, Beutels P, (2010) The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands. Eur J Health Econ 11: 543-554.
19. Dominguez A, Alonso J, Astray J, Baricot M, Cantón R, et al. (2011) Risk factors of Influenza (H1N1) 2009 hospitalization and effectiveness of pharmaceutical and nonpharmaceutical interventions in its prevention. A case-control study. Rev Esp Salud Publica 85: 3-15.
20. Pachon J, Falguer M, Gudiol F, Sabria M, Alvarez Lerma F, et al. (2010) Infecciones de las vías respiratorias Inferiores. Available at http://www.seimc.org/documentos/protocolos/clinicos/. [Accessed March 1st 2010].
21. Serrano Herranz R, (2010) Infecciones de las vías respiratorias Inferiores. Available at http://www.fesemi.org/. [Accessed March 1st 2010].
22. Domingo-Salvany A, Regidor E, Alonso J, Alvarez-Dardet C, (2000) [Proposal for a social class measure. Working Group of the Spanish Society of Epidemiology and the Spanish Society of Family and Community Medicine]. Aten Primaria 25: 350-363.
23. Instituto Catalán de Salud (2010) Revisión de precios públicos correspondientes a los servicios sanitarios. sobre la. Diari Oficial de la Generalitat de Catalunya 5325: SLT/383/2009.
24. Concejalía de Sanidad (2010) Precios públicos por las prestaciones de los servicios y actividades de naturaleza sanitaria de la red de centros de la comunidad de Madrid. Boletín Oficial de la Comunidad de Madrid ORDEN 629/2009.
25. CMP Medicom Editorial, S.A. (2010) Vademecum.es. Available at http://www.vademecum.es [Accessed February 21st, 2010].
26. Teruel A, (2011) Francia vende su excedente de vacunas de la gripe A. Available at http://www.elpais.com/articulo/sociedad/Francia/vende/excedente/vacunas/gripe/elpepusoc/20100104elpepisoc_4/Tes. [Accessed February 21st, 2010].
27. Cots F, Chiarello P, García Alzórriz E, Peláes E, Castells X, Raventós J, (2010) Cost de l'activitat asistencial. Variable de resultat per la gestió clínica. pp. 14-25 Available at http://www10.gencat.cat/catsalut/cat/publicacions_economia_sanitaria.htm. CatSalut, Servei Català de la Salut.
28. Instituto Nacional de Estadística (2010) Encuesta anual de coste laboral 2008. Available at http://www.ine.es/jaxi/menu.do?type=pcaxis&path=/t22/p132&file=inebase&N=&L=0 [Accessed February 10th, 2010].
29. Belongia EA, Irving SA, Waring SC, Coleman LA, Meece JK, et al. (2010) Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 304: 1091-1098.
30. Sander B, Bauch CT, Fisman D, Fowler RA, Kwong JC, et al. (2010) Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience. Vaccine 28: 6210-6220.
31. Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, et al. (2010) Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine 28: 2370-2384.
32. Cox F, Khan ZM, Schweinle JE, Okamoto L, McLaughlin T, (2000) Cost associated with the treatment of influenza in a managed care setting. Med Gen Med 2: E34.
33. Jefferson T, Jones M, Doshi P, Del Mar C, Dooley L, et al. (2010) Neuraminidase inhibitors for preventing and treating influenza in healthy adults: a Cochrane review. Health Technol Assess 14: 355-458.
34. Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, et al. (2009) Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis 9: 537-545.
35. Keech M, Beardsworth P, (2008) The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics 26: 911-924.
36. Flusurvey. Available at http://flusurvey.lshtm.ac.uk/. [Accessed May 15th, 2011].
37. Gisbert JP, Cooper A, Karagiannis D, Hatlebakk J, Agreus L, et al. (2009) Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Health Qual Life Outcomes 7: 90-96.
38. Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, Edwards KM, et al. (2010) High costs of influenza: Direct medical costs of influenza disease in young children. Vaccine 28: 4913-4919.
39. Loza E, Lopez-Gomez JM, Abasolo L, Maese J, Carmona L, et al. (2009) Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum 61: 158-165.
40. Scholze J, Alegria E, Ferri C, Langham S, Stevens W, et al. (2010) Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. BMC Public Health 10: 529-540.
41. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, et al. (2009) Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 339: b5213-b5220.
42. Xue Y, Kristiansen IS, de Blasio BF, (2010) Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave. BMC Public Health 10: 724.
43. Duncan B, (2009) How the media reported the first days of the pandemic (H1N1) 2009: results of EU-wide media analysis. Euro Surveill 14: 19286-19288.